1. Introduction {#sec1}
===============

Mathematical models for differential equations have been widely applied in various fields \[[@B1]--[@B7]\]. Specifically, they have had a realistic significance to analyze the dynamical behaviors in the field of mathematical biology \[[@B8]--[@B17]\], which obtained some novel results.

In fact, the main meaning of the research of infectious disease dynamics is to make people more comprehensively and deeply understand the epidemic regularity of infectious disease; then more effective control strategies are adopted to provide better theoretical support for the prevention and control of epidemics. To this end, many mathematical biology workers considered more realistic factors in the course of the study, such as population size change, migration, cross infection, and other practical factors. In the course of epidemics and outbreaks of infectious diseases, people always take various measures to control the epidemic in order to minimize the harm of epidemic diseases. Quarantine is one of the important means to prevent and control epidemic diseases; it has been used to control contagious diseases with some success. Specifically, during the severe acute respiratory syndrome (SARS) outbreak in 2002, remarkable results were also achieved. Among them, mathematical models have been used to investigate their impact on the dynamics of infectious diseases under quarantine \[[@B18]--[@B22]\], which attracts deep research interest of many mathematicians and biologists. Recently, Hethcote et al. \[[@B21]\] considered an SIQR (susceptible-infected-quarantined-recovered) model with quarantine-adjusted incidence. The system can be expressed as follows:$$\begin{matrix}
{\overset{˙}{S}\operatorname{} = \Lambda - \frac{\beta SI}{\overset{\sim}{N} - Q} - \mu S,} \\
 \\
{\overset{˙}{I}\operatorname{} = \frac{\beta SI}{\overset{\sim}{N} - Q} - \left( {\lambda + \varepsilon_{1} + \gamma + \mu} \right)I,} \\
 \\
{\overset{˙}{Q}\operatorname{} = \lambda I - \left( {\varphi + \varepsilon_{2} + \mu} \right)Q,} \\
 \\
{\overset{˙}{R}\operatorname{} = \gamma I + \varphi Q - \mu R,} \\
 \\
\end{matrix}$$where the total population size is given by $\overset{\sim}{N}(t) = S(t) + I(t) + Q(t) + R(t)$, Λ is the inflow rate corresponding to birth and immigration, and *μ* is the outflow rate corresponding to natural death and emigration. Since the quarantine process, using the standard incidence $\left( {{\beta I}/\overset{\sim}{N}} \right)S$, the contact rate ${\beta Q}/\overset{\sim}{N}$ with the quarantined fraction $Q/\overset{\sim}{N}$ does not occur. Hence the standard incidence is replaced by ${\beta SI}/\left( {\overset{\sim}{N} - Q} \right)$ (it is called quarantine-adjusted incidence); here *β* is the transmission coefficient between susceptible individuals and infected individuals. *λ* is the quarantine rate of infected individuals, *φ* is the recovery rate of quarantined individuals, and *ε*~1~ and *ε*~2~ stand for the rate of disease-related death of infected and quarantined individuals, respectively. *γ* is the recovery rate of infected individuals. Furthermore, all the parameters are positive and the region $\overset{\sim}{D} = \left\{ {(S,I,Q,R) \mid S \geq 0,{\,\,}I \geq 0,{\,\,}Q \geq 0,{\,\,}R \geq 0,{\,\,}S + I + Q + R \leq {\Lambda/\mu}} \right\}$ is a positively invariant set of system ([1](#EEq1){ref-type="disp-formula"}). In the region $\overset{\sim}{D}$, they established the basic reproduction number *R*~0~, which determines disease extinction or permanence, where$$\begin{matrix}
{R_{0} = \frac{\beta}{\lambda + \varepsilon_{1} + \gamma + \mu}.} \\
\end{matrix}$$Meanwhile, they analyzed the global dynamics of system ([1](#EEq1){ref-type="disp-formula"}) and derived the equilibria (including the disease-free equilibrium and the endemic equilibrium) and their global stability. In addition, the parameter conditions for the existence of a Hopf bifurcation are obtained.

In the real world, with the development of modern medicine, vaccination has become an important strategy for disease prevention and control in addition to quarantine, and numerous scholars have investigated the effect of vaccination on disease \[[@B23]--[@B30]\]. For another, many infectious diseases incubate inside the hosts for a period of time before becoming infectious, so it is very meaningful to consider the effect of the incubation period. Motivated by the aforementioned work, this paper considers an SEIQR (susceptible-exposed-infected-quarantined-recovered) epidemic model with imperfect vaccination, which is described by the following system:$$\begin{matrix}
{\overset{˙}{S}\operatorname{} = \Lambda - \frac{\left( {1 - \delta} \right)\beta SI}{N - Q} - \frac{\delta\left( {1 - p} \right)\beta SI}{N - Q} - \left( {\delta p + \mu} \right)S,} \\
 \\
{\overset{˙}{E}\operatorname{} = \frac{\left( {1 - \delta} \right)\beta SI}{N - Q} + \frac{\delta\left( {1 - p} \right)\beta SI}{N - Q} - \left( {\alpha + \mu} \right)E,} \\
 \\
{\overset{˙}{I}\operatorname{} = \alpha E - \left( {\lambda + \varepsilon_{1} + \gamma + \mu} \right)I,} \\
 \\
{\overset{˙}{Q}\operatorname{} = \lambda I - \left( {\varphi + \varepsilon_{2} + \mu} \right)Q,} \\
 \\
{\overset{˙}{R}\operatorname{} = \delta pS + \gamma I + \varphi Q - \mu R,} \\
 \\
\end{matrix}$$where the total population size is given by *N*(*t*) = *S*(*t*) + *E*(*t*) + *I*(*t*) + *Q*(*t*) + *R*(*t*), *δ*  (0 ≤ *δ* \< 1) is the vaccine coverage rate, *p*  (0 ≤ *p* ≤ 1) is the vaccine efficacy, and *α* is the rate at which the exposed individuals become infected individuals. Other parameters are the same as in system ([1](#EEq1){ref-type="disp-formula"}). Now we assume that all the parameters are positive constants here except that *δ*, *p* are nonnegative constants. Clearly, the region *D* = {(*S*, *E*, *I*, *Q*, *R*)∣*S* ≥ 0, *E* ≥ 0, *I* ≥ 0, *Q* ≥ 0, *R* ≥ 0, *S* + *E* + *I* + *Q* + *R* ≤ Λ/*μ*} is a positively invariant set of system ([3](#EEq2){ref-type="disp-formula"}). For system ([3](#EEq2){ref-type="disp-formula"}), the basic reproduction number is$$\begin{matrix}
{R_{1} = \frac{\mu\left( {1 - \delta p} \right)\beta\alpha}{\left( {\delta p + \mu} \right)\left( {\alpha + \mu} \right)\left( {\lambda + \varepsilon_{1} + \gamma + \mu} \right)}} \\
\end{matrix}$$and it has the following properties:When *R*~1~ ≤ 1 holds, system ([3](#EEq2){ref-type="disp-formula"}) has a unique disease-free equilibrium *E*~0~ = (*S*~0~, 0,0, 0, *R*~0~) = (Λ/(*δp* + *μ*), 0,0, 0, *δp*Λ/*μ*(*δp* + *μ*)) which is globally asymptotically stable in the region *D*. That means the epidemic diseases will die out and the total individuals will become the susceptible and recovered individuals.When *R*~1~ \> 1 holds, system ([3](#EEq2){ref-type="disp-formula"}) has a unique globally asymptotically stable positive equilibrium *E*^*∗*^ = (*S*^*∗*^, *E*^*∗*^, *I*^*∗*^, *Q*^*∗*^, *R*^*∗*^) in the region *D*, which means the epidemic diseases will persist.

In the natural world, deterministic model is not enough to describe the species activities. Sometimes, the species activities may be disturbed by uncertain environmental noises. Consequently, some parameters should be stochastic \[[@B31]--[@B40]\]. There is no denying that this phenomenon is ubiquitous in the ecosystem. Therefore numerous scholars have introduced the effect of stochastic perturbation on diseases \[[@B41]--[@B50]\]. To the best of our knowledge, the research on global dynamics of the stochastic SEIQR epidemic model with imperfect vaccination is not too much yet. In this paper, to make system ([3](#EEq2){ref-type="disp-formula"}) more reasonable and realistic, we assume the environmental noise is directly proportional to *S*(*t*), *E*(*t*), *I*(*t*), *Q*(*t*), and *R*(*t*). Then corresponding to system ([3](#EEq2){ref-type="disp-formula"}), a stochastic version can be reached by$$\begin{matrix}
{\operatorname{}dS} \\
{\mspace{560mu} = \left\lbrack {\Lambda - \frac{\left( {1 - \delta} \right)\beta SI}{N - Q} - \frac{\delta\left( {1 - p} \right)\beta SI}{N - Q} - \left( {\delta p + \mu} \right)S} \right\rbrack dt} \\
{\mspace{2610mu} + \sigma_{1}SdB_{1}\left( { t} \right),} \\
{\operatorname{}dE} \\
{\mspace{560mu} = \left\lbrack {\frac{\left( {1 - \delta} \right)\beta SI}{N - Q} + \frac{\delta\left( {1 - p} \right)\beta SI}{N - Q} - \left( {\alpha + \mu} \right)E} \right\rbrack dt} \\
{\mspace{2610mu} + \sigma_{2}EdB_{2}\left( { t} \right),} \\
{dI = \left\lbrack {\alpha E - \left( {\lambda + \varepsilon_{1} + \gamma + \mu} \right)I} \right\rbrack dt + \sigma_{3}IdB_{3}\left( { t} \right),} \\
{dQ = \left\lbrack {\lambda I - \left( {\varphi + \varepsilon_{2} + \mu} \right)Q} \right\rbrack dt + \sigma_{4}QdB_{4}\left( { t} \right),} \\
{dR = \left( {\delta pS + \gamma I + \varphi Q - \mu R} \right)dt + \sigma_{5}RdB_{5}\left( { t} \right),} \\
\end{matrix}$$where *B*~*i*~(*t*)  (*i* = 1,2, 3,4, 5) is the mutually independent standard Wiener process with *B*~*i*~(0) = 0 a.s. *σ*~*i*~(*t*)  (*i* = 1,2, 3,4, 5) is a continuous and bounded function for any *t* ≥ 0 and *σ*~*i*~^2^(*t*)  (*i* = 1,2, 3,4, 5) are the intensities of Wiener processes.

In this paper, we are mainly concerned with two interesting problems as follows:(P1) Under what parameter conditions, will the disease die out?(P2) Under what conditions, will system ([5](#EEq3){ref-type="disp-formula"}) have a unique ergodic stationary distribution?

Throughout this paper, let (*Ω*, *ℱ*, {*ℱ*}~*t*≥0~, *ℙ*) be a complete probability space with a filtration {*ℱ*~*t*~}~*t*≥0~ satisfying the usual conditions (i.e., it is increasing and right continuous while *ℱ*~0~ contains all *ℙ*-null sets). Further *B*~*i*~(*t*)  (*i* = 1,2, 3,4, 5) is defined on the complete probability space.

For simplicity and convenience, we introduce the following notations:*ℝ*~+~ = \[0, +*∞*), *ℝ*~+~^5^ = {*x* = (*x*~1~, *x*~2~, *x*~3~, *x*~4~, *x*~5~) ∈ *ℝ*^5^ : *x*~*i*~ \> 0  (*i* = 1,2, 3,4, 5)}.For an integrable function *x*(*t*)∈\[0, +*∞*), 〈*x*(*t*)〉 = (1/*t*)∫~0~^*t*^*x*(*r*)d*r*.*a*∧*b* = min⁡{*a*, *b*}, *a*∨*b* = max⁡{*a*, *b*}.

2. Global Positive Solution {#sec2}
===========================

To investigate the dynamical behaviors of a population system, we first concern the global existence and positivity of the solutions of system ([5](#EEq3){ref-type="disp-formula"}).

Lemma 1 .For any given initial value (*S*(0), *E*(0), *I*(0), *Q*(0), *R*(0)) ∈ *ℝ*~+~^5^, system ([5](#EEq3){ref-type="disp-formula"}) has a unique positive local solution (*S*(*t*), *E*(*t*), *I*(*t*), *Q*(*t*), *R*(*t*)) for *t* ∈ \[−*ω*, *τ*~*e*~), where *τ*~*e*~ is the explosion time \[[@B51]\].

Theorem 2 .For any given initial value (*S*(0), *E*(0), *I*(0), *Q*(0), *R*(0)) ∈ *ℝ*~+~^5^, system ([5](#EEq3){ref-type="disp-formula"}) has a unique positive solution (*S*(*t*), *E*(*t*), *I*(*t*), *Q*(*t*), *R*(*t*)) ∈ *ℝ*~+~^5^ on *t* ≥ 0 a.s.

ProofThe following proof is divided into two parts.*Part I*. By [Lemma 1](#lem2.1){ref-type="statement"}, it is easy to see that system ([5](#EEq3){ref-type="disp-formula"}) has a unique positive local solution (*S*(*t*), *E*(*t*), *I*(*t*), *Q*(*t*), *R*(*t*)) for any given initial value (*S*(0), *E*(0), *I*(0), *Q*(0), *R*(0)) ∈ *ℝ*~+~^5^.*Part II*. Now we prove that the positive solution is global, that is, *τ*~*e*~ = *∞* a.s. Let *k*~0~ ≥ 0 be sufficiently large such that *S*(0), *E*(0), *I*(0), *Q*(0), and *R*(0) all lie in \[1/*k*~0~, *k*~0~\]. For each integer *k* ≥ *k*~0~, let us define the stopping time as follows:$$\begin{matrix}
{\tau_{k} = {\inf\left\{ { t \in \left\lbrack { - \omega,\tau_{e}} \right\}:S\left\{ { t} \right\} \notin \left\{ {\frac{1}{k},k} \right\},E\left\{ { t} \right\}\mspace{1800mu} \notin \left\{ {\frac{1}{k},k} \right\},I\left\{ { t} \right\} \notin \left\{ {\frac{1}{k},k} \right\},Q\left\{ { t} \right\} \notin \left\{ {\frac{1}{k},k} \right\}\text{  or  }R\left\{ { t} \right\}\mspace{1800mu} \notin \left\{ {\frac{1}{k},k} \right\}} \right\}},} \\
\end{matrix}$$where we define inf⁡*∅* = *∞* (*∅* represents the empty set). Evidently, *τ*~*k*~ is strictly increasing when *k* → *∞*. Let *τ*~*∞*~ = lim~*k*→*∞*~*τ*~*k*~; thus *τ*~*∞*~ ≤ *τ*~*e*~ a.s. So we just need to show that *τ*~*∞*~ = *∞* a.s. If *τ*~*∞*~ = *∞* is untrue, then there exist two constants *T* \> 0 and *ς* ∈ (0,1) such that *ℙ*{*τ*~*∞*~ ≤ *T*} \> *ς*. Thus there exists *k*~1~ ≥ *k*~0~  (*k*~1~ ∈ *N*~+~) such that$$\begin{matrix}
{\mathbb{P}\left\{ {\tau_{k} \leq T} \right\} \geq \varsigma,\mspace{1800mu} k \geq k_{1}.} \\
\end{matrix}$$Define a *C*^2^-function $\left. \hat{V}:\mathbb{R}_{+}^{5}\rightarrow\mathbb{R}_{+} \right.$ by$$\begin{matrix}
{\hat{V}\left( { S,E,I,Q,R} \right) = S - 1 - {\ln S} + E - 1 - {\ln E} + I - 1} \\
{\mspace{2060mu} - {\ln I} + Q - 1 - {\ln Q} + R - 1\mspace{2060mu} - {\ln R}.} \\
\end{matrix}$$Applying Itô\'s formula and system ([5](#EEq3){ref-type="disp-formula"}), we have$$\begin{matrix}
{d\hat{V} = \mathcal{L}\hat{V}dt + \sigma_{1}\left( { S - 1} \right)dB_{1}\left( t \right) + \sigma_{2}\left( { E - 1} \right)dB_{2}\left( t \right)} \\
{\mspace{2060mu} + \sigma_{3}\left( { I - 1} \right)dB_{3}\left( t \right) + \sigma_{4}\left( { Q - 1} \right)dB_{4}\left( t \right)\mspace{2060mu} + \sigma_{5}\left( { R - 1} \right)dB_{5}\left( t \right),} \\
\end{matrix}$$where$$\begin{matrix}
{\operatorname{}\mathcal{L}\hat{V} = \left( { 1 - \frac{1}{S}} \right)} \\
{\mspace{1800mu} \cdot \left\lbrack {\Lambda - \frac{\left( {1 - \delta} \right)\beta SI}{N - Q} - \frac{\delta\left( {1 - p} \right)\beta SI}{N - Q} - \left( {\delta p + \mu} \right)S} \right\rbrack} \\
{\mspace{1800mu} + \left( { 1 - \frac{1}{E}} \right)} \\
{\mspace{1800mu} \cdot \left\lbrack {\frac{\left\lbrack {1 - \delta} \right\rbrack\beta SI}{N - Q} + \frac{\delta\left\lbrack {1 - p} \right\rbrack\beta SI}{N - Q} - \left\lbrack {\alpha + \mu} \right\rbrack E} \right\rbrack} \\
{\mspace{1800mu} + \left( { 1 - \frac{1}{I}} \right)\left\lbrack {\alpha E - \left\lbrack {\lambda + \varepsilon_{1} + \gamma + \mu} \right\rbrack I} \right\rbrack + \left( { 1 - \frac{1}{Q}} \right)} \\
{\mspace{1800mu} \cdot \left\lbrack {\lambda I - \left\lbrack {\varphi + \varepsilon_{2} + \mu} \right\rbrack Q} \right\rbrack + \left( { 1 - \frac{1}{R}} \right)} \\
{\mspace{1800mu} \cdot \left( {\delta pS + \gamma I + \varphi Q - \mu R} \right)} \\
{\mspace{1800mu} + \frac{1}{2}\left( {\sigma_{1}^{2} + \sigma_{2}^{2} + \sigma_{3}^{2} + \sigma_{4}^{2} + \sigma_{5}^{2}} \right) = \Lambda + \delta p + \alpha + \lambda} \\
{\mspace{1800mu} + \gamma + \varphi + \varepsilon_{1} + \varepsilon_{2} + 5\mu + \frac{\left( {1 - \delta p} \right)\beta I}{S + E + I + R}} \\
{\mspace{1800mu} - \mu\left( { S + E + I + Q + R} \right) - \varepsilon_{1}I - \varepsilon_{1}Q - \frac{\Lambda}{S}} \\
{\mspace{1800mu} - \frac{\left( {1 - \delta p} \right)\beta SI}{E\left( {S + E + I + R} \right)} - \frac{\alpha E}{I} - \frac{\lambda I}{Q} - \frac{\delta pS}{R} - \frac{\gamma I}{R}} \\
{\mspace{1800mu} - \frac{\varphi Q}{R} + \frac{1}{2}\left( {\sigma_{1}^{2} + \sigma_{2}^{2} + \sigma_{3}^{2} + \sigma_{4}^{2} + \sigma_{5}^{2}} \right) \leq \Lambda + \delta p + \alpha} \\
{\mspace{1800mu} + \lambda + \gamma + \varphi + \varepsilon_{1} + \varepsilon_{2} + 5\mu + \left( { 1 - \delta p} \right)\beta} \\
{\mspace{1800mu} + \frac{1}{2}\left( {\sigma_{1}^{2} + \sigma_{2}^{2} + \sigma_{3}^{2} + \sigma_{4}^{2} + \sigma_{5}^{2}} \right) = M_{0},} \\
\end{matrix}$$and here *M*~0~ is a positive constant. Hence$$\begin{matrix}
{d\hat{V} \leq M_{0}dt + \sigma_{1}\left( { S - 1} \right)dB_{1}\left( t \right) + \sigma_{2}\left( { E - 1} \right)dB_{2}\left( t \right)} \\
{\mspace{2060mu} + \sigma_{3}\left( { I - 1} \right)dB_{3}\left( t \right) + \sigma_{4}\left( { Q - 1} \right)dB_{4}\left( t \right)\mspace{2060mu} + \sigma_{5}\left( { R - 1} \right)dB_{5}\left( t \right).} \\
\end{matrix}$$Integrating both sides of ([11](#EEq5){ref-type="disp-formula"}) from 0 to *τ*~*k*~∧*T* and then taking the expectation, we have$$\begin{matrix}
{\operatorname{}\mathbb{E}\hat{V}\left( { S\left( {\tau_{k} \land T} \right),E\left( {\tau_{k} \land T} \right),I\left( {\tau_{k} \land T} \right),Q\left( {\tau_{k} \land T} \right),\mspace{1800mu} R\left( {\tau_{k} \land T} \right)} \right) \leq \hat{V}\left( { S\left( { 0} \right),E\left( { 0} \right),I\left( { 0} \right),Q\left( { 0} \right),R\left( { 0} \right)} \right)} \\
{\mspace{1800mu} + \mathbb{E}{\int\limits_{0}^{\tau_{k} \land T}{M_{0}dt}} \leq \hat{V}\left( { S\left( { 0} \right),E\left( { 0} \right),I\left( { 0} \right),Q\left( { 0} \right),R\left( { 0} \right)} \right)} \\
{\mspace{1800mu} + M_{0}T.} \\
\end{matrix}$$Set *Ω*~*k*~ = {*τ*~*k*~ ≤ *T*}, *k* ≥ *k*~1~ and by ([7](#EEq4){ref-type="disp-formula"}) we can get that *P*(*Ω*~*k*~) ≥ *ς*. Notice that, for every *ω* ∈ *Ω*~*k*~, there exists *S*(*τ*~*k*~, *ω*), *E*(*τ*~*k*~, *ω*), *I*(*τ*~*k*~, *ω*), *Q*(*τ*~*k*~, *ω*), or *R*(*τ*~*k*~, *ω*) which equals either 1/*k* or *k*. Thus$$\begin{matrix}
{\operatorname{}\hat{V}\left( { S\left( {\tau_{k},\omega} \right),E\left( {\tau_{k},\omega} \right),I\left( {\tau_{k},\omega} \right),Q\left( {\tau_{k},\omega} \right),R\left( {\tau_{k},\omega} \right)} \right)} \\
{\mspace{1800mu} \geq \left( {\frac{1}{k} - 1 - {\ln\frac{1}{k}}} \right) \land \left( { k - 1 - {\ln k}} \right).} \\
\end{matrix}$$By virtue of ([12](#EEq6){ref-type="disp-formula"}) and ([13](#EEq7){ref-type="disp-formula"}), one has $$\begin{matrix}
{\operatorname{}\hat{V}\left( { S\left( { 0} \right),E\left( { 0} \right),I\left( { 0} \right),Q\left( { 0} \right),R\left( { 0} \right)} \right) + M_{0}T} \\
{\mspace{1800mu} \geq \mathbb{E}\left\lbrack { 1_{\Omega_{k}{\lbrack\omega\rbrack}}\hat{V}\left\lbrack { S\left\lbrack {\tau_{k},\omega} \right\rbrack,E\left\lbrack {\tau_{k},\omega} \right\rbrack,I\left\lbrack {\tau_{k},\omega} \right\rbrack,\mspace{1800mu} Q\left\lbrack {\tau_{k},\omega} \right\rbrack,R\left\lbrack {\tau_{k},\omega} \right\rbrack} \right\rbrack} \right\rbrack \geq \varsigma\left\lbrack {\left\lbrack {\frac{1}{k} - 1 - {\ln\frac{1}{k}}} \right\rbrack \land \left( { k - 1\mspace{1800mu} - {\ln k}} \right)} \right\rbrack,} \\
\end{matrix}$$and here 1~*Ω*~*k*~(*ω*)~ is the indicator function of *Ω*~*k*~(*ω*). Let *k* → *∞*, which implies $$\begin{matrix}
{\infty > \hat{V}\left( { S\left( { 0} \right),E\left( { 0} \right),I\left( { 0} \right),Q\left( { 0} \right),R\left( { 0} \right)} \right) + M_{0}T = \infty} \\
\end{matrix}$$is a contradiction. Obviously, we get that *τ*~*∞*~ = *∞*. This completes the proof of [Theorem 2](#thm2.1){ref-type="statement"}.

3. Extinction {#sec3}
=============

In this section, we mainly explore the parameter conditions for extinction of the disease in system ([5](#EEq3){ref-type="disp-formula"}). Before proving the main results, we first give a useful lemma as follows.

Lemma 3 .For any given initial value (*S*(0), *E*(0), *I*(0), *Q*(0), *R*(0)) ∈ *ℝ*~+~^5^, the solution (*S*(*t*), *E*(*t*), *I*(*t*), *Q*(*t*), *R*(*t*)) of the system ([5](#EEq3){ref-type="disp-formula"}) has the following properties:$$\begin{matrix}
{{\lim\limits_{t\rightarrow\infty}\frac{S\left( t \right)}{t}}\operatorname{} = 0,} \\
 \\
{{\lim\limits_{t\rightarrow\infty}\frac{E\left( t \right)}{t}}\operatorname{} = 0,} \\
 \\
{{\lim\limits_{t\rightarrow\infty}\frac{I\left( t \right)}{t}}\operatorname{} = 0,} \\
 \\
{{\lim\limits_{t\rightarrow\infty}\frac{Q\left( t \right)}{t}}\operatorname{} = 0,} \\
 \\
{{\lim\limits_{t\rightarrow\infty}\frac{R\left( t \right)}{t}}\operatorname{} = 0} \\
 \\
{\mspace{3330mu}\text{a.s.}} \\
\end{matrix}$$Furthermore, when *μ* \> (1/2)(*σ*~1~^2^∨*σ*~2~^2^∨*σ*~3~^2^∨*σ*~4~^2^∨*σ*~5~^2^) holds, then$$\begin{matrix}
{{\lim\limits_{t\rightarrow\infty}{\frac{1}{t}{\int\limits_{0}^{t}{S\left( { r} \right)dB_{1}\left( r \right)}}}}\operatorname{} = 0,} \\
 \\
{{\lim\limits_{t\rightarrow\infty}{\frac{1}{t}{\int\limits_{0}^{t}{E\left( { r} \right)dB_{2}\left( r \right)}}}}\operatorname{} = 0,} \\
 \\
{{\lim\limits_{t\rightarrow\infty}{\frac{1}{t}{\int\limits_{0}^{t}{I\left( { r} \right)dB_{3}\left( r \right)}}}}\operatorname{} = 0,} \\
 \\
{{\lim\limits_{t\rightarrow\infty}{\frac{1}{t}{\int\limits_{0}^{t}{Q\left( { r} \right)dB_{4}\left( r \right)}}}}\operatorname{} = 0,} \\
 \\
{{\lim\limits_{t\rightarrow\infty}{\frac{1}{t}{\int\limits_{0}^{t}{R\left( { r} \right)dB_{5}\left( r \right)}}}}\operatorname{} = 0} \\
 \\
{\mspace{3330mu}\text{a.s.}} \\
\end{matrix}$$

ProofThe proof of [Lemma 3](#lem3.1){ref-type="statement"} is similar to \[[@B25], [@B41]\]; thus we omit it here.

Theorem 4 .Let *μ* \> (1/2)(*σ*~1~^2^∨*σ*~2~^2^∨*σ*~3~^2^∨*σ*~4~^2^∨*σ*~5~^2^). For any given initial value (*S*(0), *E*(0), *I*(0), *Q*(0), *R*(0)) ∈ *ℝ*~+~^5^, if$$\begin{matrix}
{{\overset{\sim}{R}}^{\ast} ≔ \frac{2\alpha\left( {1 - \delta p} \right)\beta\left( {\alpha + \mu} \right)}{\left( {\lambda + \varepsilon_{1} + \gamma + \mu + {\sigma_{3}^{2}/2}} \right)\left( {\alpha + \mu} \right)^{2} \land \left( {{\alpha^{2}\sigma_{2}^{2}}/2} \right)}} \\
{< 1} \\
\end{matrix}$$holds, then$$\begin{matrix}
{{\lim\limits_{t\rightarrow\infty}{E\left( { t} \right)}} = {\lim\limits_{t\rightarrow\infty}{I\left( { t} \right)}} = {\lim\limits_{t\rightarrow\infty}{Q\left( { t} \right)}} = 0\mspace{1800mu}\text{a.s.}} \\
\end{matrix}$$Moreover,$$\begin{matrix}
{{\lim\limits_{t\rightarrow\infty}\left\langle { S} \right\rangle}\operatorname{} = \frac{\Lambda}{\delta p + \mu} = S_{0},} \\
 \\
{{\lim\limits_{t\rightarrow\infty}\left\langle { R} \right\rangle}\operatorname{} = \frac{\delta p\Lambda}{\mu\left( {\delta p + \mu} \right)} = R_{0}} \\
 \\
{\mspace{13770mu}\text{a.s.}} \\
\end{matrix}$$

ProofDefine a differentiable function *V*~0~ by$$\begin{matrix}
{V_{0} = {\ln\left\lbrack {\alpha E\left\lbrack { t} \right\rbrack + \left\lbrack {\alpha + \mu} \right\rbrack I\left\lbrack { t} \right\rbrack} \right\rbrack}.} \\
\end{matrix}$$From Itô\'s formula and system ([5](#EEq3){ref-type="disp-formula"}), we have$$\begin{matrix}
{dV_{0} = \left\{ {\frac{{{\alpha\left( {1 - \delta p} \right)\beta SI}/\left\{ {S + E + I + R} \right\}} - \left( {\alpha + \mu} \right)\left( {\lambda + \varepsilon_{1} + \gamma + \mu} \right)I}{\alpha E + \left( {\alpha + \mu} \right)I} - \frac{\alpha^{2}\sigma_{2}^{2}E^{2} + \left\{ {\alpha + \mu} \right\}^{2}\sigma_{3}^{2}I^{2}}{2\left\lbrack {\alpha E + \left\lbrack {\alpha + \mu} \right\rbrack I} \right\rbrack^{2}}} \right\} dt} \\
{\mspace{2060mu} + \frac{\alpha\sigma_{2}E}{\alpha E + \left( {\alpha + \mu} \right)I}dB_{2}\left( { t} \right) + \frac{\left( {\alpha + \mu} \right)\sigma_{3}I}{\alpha E + \left( {\alpha + \mu} \right)I}dB_{3}\left( { t} \right)} \\
{\leq \left\{ {\frac{\alpha\left( {1 - \delta p} \right)\beta}{\alpha + \mu} - \frac{\left\{ {\lambda + \varepsilon_{1} + \gamma + \mu + {\sigma_{3}^{2}/2}} \right\}\left\{ {\alpha + \mu} \right\}^{2}I^{2} + \left\{ {{\alpha^{2}\sigma_{2}^{2}}/2} \right\} E^{2}}{\left\lbrack {\alpha E + \left\lbrack {\alpha + \mu} \right\rbrack I} \right\rbrack^{2}}} \right\} dt + \frac{\alpha\sigma_{2}E}{\alpha E + \left( {\alpha + \mu} \right)I}dB_{2}\left( { t} \right)} \\
{\mspace{2060mu} + \frac{\left( {\alpha + \mu} \right)\sigma_{3}I}{\alpha E + \left( {\alpha + \mu} \right)I}dB_{3}\left( { t} \right)} \\
{\leq \left\{ {\frac{\alpha\left( {1 - \delta p} \right)\beta}{\alpha + \mu} - \frac{\left\{ {\lambda + \varepsilon_{1} + \gamma + \mu + {\sigma_{3}^{2}/2}} \right\}\left\{ {\alpha + \mu} \right\}^{2} \land \left\{ {{\alpha^{2}\sigma_{2}^{2}}/2} \right\}}{2\left\{ {\alpha + \mu} \right\}^{2}}} \right\} dt + \frac{\alpha\sigma_{2}E}{\alpha E + \left( {\alpha + \mu} \right)I}dB_{2}\left( { t} \right)} \\
{\mspace{2060mu} + \frac{\left( {\alpha + \mu} \right)\sigma_{3}I}{\alpha E + \left( {\alpha + \mu} \right)I}dB_{3}\left( { t} \right).} \\
\end{matrix}$$Integrating from 0 to *t* and dividing by *t* on both sides of ([22](#EEq8){ref-type="disp-formula"}), we have $$\begin{matrix}
{\operatorname{}\frac{\ln\left\lbrack {\alpha E\left\lbrack t \right\rbrack + \left\lbrack {\alpha + \mu} \right\rbrack I\left\lbrack t \right\rbrack} \right\rbrack}{t}} \\
{\mspace{1800mu} \leq \frac{\alpha\left( {1 - \delta p} \right)\beta}{\alpha + \mu}} \\
{\mspace{3860mu} - \frac{\left( {\lambda + \varepsilon_{1} + \gamma + \mu + {\sigma_{3}^{2}/2}} \right)\left( {\alpha + \mu} \right)^{2} \land \left( {{\alpha^{2}\sigma_{2}^{2}}/2} \right)}{2\left( {\alpha + \mu} \right)^{2}}} \\
{\mspace{3860mu} + \frac{\ln\left\lbrack {\alpha E\left\lbrack 0 \right\rbrack + \left\lbrack {\alpha + \mu} \right\rbrack I\left\lbrack 0 \right\rbrack} \right\rbrack}{t}} \\
{\mspace{3860mu} + \frac{\alpha\sigma_{2}}{t}{\int\limits_{0}^{t}{\frac{E\left( r \right)}{\alpha E\left( r \right) + \left( {\alpha + \mu} \right)I\left( r \right)}dB_{2}\left( { r} \right)}}} \\
{\mspace{3860mu} + \frac{\left( {\alpha + \mu} \right)\sigma_{3}}{t}{\int\limits_{0}^{t}{\frac{I\left( r \right)}{\alpha E\left( r \right) + \left( {\alpha + \mu} \right)I\left( r \right)}dB_{3}\left( { r} \right)}}.} \\
\end{matrix}$$Making use of [Lemma 3](#lem3.1){ref-type="statement"}, we have$$\begin{matrix}
{\operatorname{}{\underset{t\rightarrow\infty}{\lim\,\sup}\frac{\ln\left\lbrack {\alpha E\left\lbrack t \right\rbrack + \left\lbrack {\alpha + \mu} \right\rbrack I\left\lbrack t \right\rbrack} \right\rbrack}{t}}} \\
{\mspace{1800mu} \leq \frac{\alpha\left( {1 - \delta p} \right)\beta}{\alpha + \mu}} \\
{\mspace{3860mu} - \frac{\left( {\lambda + \varepsilon_{1} + \gamma + \mu + {\sigma_{3}^{2}/2}} \right)\left( {\alpha + \mu} \right)^{2} \land \left( {{\alpha^{2}\sigma_{2}^{2}}/2} \right)}{2\left( {\alpha + \mu} \right)^{2}}} \\
{\mspace{1800mu} < 0\mspace{1800mu}\text{a.s.},} \\
\end{matrix}$$which shows that$$\begin{matrix}
{{\lim\limits_{t\rightarrow\infty}{E\left( { t} \right)}}\operatorname{} = 0,} \\
 \\
{{\lim\limits_{t\rightarrow\infty}{I\left( { t} \right)}}\operatorname{} = 0} \\
 \\
{\mspace{3330mu}\text{a.s.}} \\
\end{matrix}$$From the fourth equation of system ([5](#EEq3){ref-type="disp-formula"}), it is easy to get that$$\begin{matrix}
{\underset{t\rightarrow\infty}{lim}Q\left( { t} \right) = 0\mspace{1800mu}\text{a.s.}} \\
\end{matrix}$$Moreover, integrating from 0 to *t* and dividing by *t* on both sides of the first equation of system ([5](#EEq3){ref-type="disp-formula"}) yield$$\begin{matrix}
{\frac{S\left( t \right) - S\left( 0 \right)}{t} = \Lambda - \left( { 1 - \delta p} \right)\beta\left\langle {\frac{SI}{N - Q}} \right\rangle} \\
{\mspace{2060mu} - \left( {\delta p + \mu} \right)\left\langle { S} \right\rangle + \frac{\sigma_{1}}{t}{\int\limits_{0}^{t}{S\left( { r} \right)dB_{1}\left( r \right)}},} \\
\end{matrix}$$and considering ([25](#EEq9){ref-type="disp-formula"}), ([26](#EEq10){ref-type="disp-formula"}), and [Lemma 3](#lem3.1){ref-type="statement"}, it then follows that$$\begin{matrix}
{{\lim\limits_{t\rightarrow\infty}\left\langle { S} \right\rangle} = \frac{\Lambda}{\delta p + \mu} = S_{0}\mspace{1800mu}\text{a.s.}} \\
\end{matrix}$$Similarly, we also get$$\begin{matrix}
{{\lim\limits_{t\rightarrow\infty}\left\langle { R} \right\rangle} = \frac{\delta p\Lambda}{\mu\left( {\delta p + \mu} \right)} = R_{0}\mspace{1800mu}\text{a.s.}} \\
\end{matrix}$$The proof of [Theorem 4](#thm3.1){ref-type="statement"} is complete.

4. Stationary Distribution and Ergodicity {#sec4}
=========================================

Ergodicity is a significant property in a population system. Recently, it attracts deep research interest of numerous scholars \[[@B52], [@B53]\]. In this section, based on the theory of Hasminskii et al. \[[@B54]\] and the Lyapunov analysis methods, we study the conditions of the existence of an ergodic stationary distribution.

Assume *X*(*t*) as a time-homogeneous Markov process in *𝔼*~*n*~ ⊂ *ℝ*^*n*^, which is described by the stochastic differential equation$$\begin{matrix}
{dX\left( { t} \right) = b\left( { X} \right)dt + {\sum\limits_{\eta = 1}^{n}{\sigma_{\eta}\left( { X} \right)dB_{\eta}\left( t \right)}},} \\
\end{matrix}$$and here *𝔼*~*n*~ stands for a *n*-dimensional Euclidean space. The diffusion matrix takes the following form:$$\begin{matrix}
{\overset{\sim}{A}\left( { x} \right) = \left( { a_{ij}\left( { x} \right)} \right),\mspace{1800mu} a_{ij}\left( x \right) = {\sum\limits_{\eta = 1}^{n}{\sigma_{\eta}^{i}\left( x \right)\sigma_{\eta}^{j}\left( x \right)}}.} \\
\end{matrix}$$

Assumption 5 .Assume that there is a bounded domain *U* ⊂ *𝔼*~*n*~ with regular boundary Γ such that $\overset{¯}{U} \subset \mathbb{E}_{n}\,\,(\overset{¯}{U}\,\, is\,\, the\,\, closure\,\, of\,\, U)$, satisfying the following properties:In the domain *U* and some neighborhood thereof, the smallest eigenvalue of the diffusion matrix $\overset{\sim}{A}(x)$ is bounded away from zero.If *x* ∈ *𝔼*~*n*~∖*U*, the mean time *τ* at which a path issuing from *x* reaches the set *U* is finite, and sup~*x*∈Θ~*𝔼*~*x*~*τ* \< *∞* for every compact subset Θ ⊂ *𝔼*~*n*~.

Lemma 6 (see \[[@B54]\]).When [Assumption 5](#assump4.1){ref-type="statement"} holds, then the Markov process *X*(*t*) has a stationary distribution *π*(·). Furthermore, when *f*(·) is a function integrable with respect to the measure *π*, then $$\begin{matrix}
{\mathbb{P}_{x}\left\{ {{\lim\limits_{T\rightarrow\infty}{\frac{1}{T}{\int\limits_{0}^{T}{f\left( { X\left( { t} \right)} \right)dt}}}} = {\int_{\mathbb{E}_{n}}{f\left( { x} \right)\pi\left( { dx} \right)}}} \right\} = 1} \\
\end{matrix}$$for all *x* ∈ *𝔼*~*n*~.

Remark 7 .To demonstrate [Assumption 5](#assump4.1){ref-type="statement"}(i) \[[@B55]\], it suffices to demonstrate that *F* is uniformly elliptical in any bounded domain *H*; here$$\begin{matrix}
{Fu = b\left( { x} \right)u_{x} + \frac{1}{2}\text{trace}\left( { A\left( { x} \right)u_{xx}} \right);} \\
\end{matrix}$$namely, there exists a positive number *Z* such that$$\begin{matrix}
{{\sum\limits_{i,j = 1}^{n}{a_{ij}\left( { x} \right)\xi_{i}\xi_{j}}} \geq Z\left| {\xi} \right|^{2},\mspace{1800mu} x \in \overset{¯}{H},\text{  }\xi \in \mathbb{R}^{n}.} \\
\end{matrix}$$To verify [Assumption 5](#assump4.1){ref-type="statement"}(ii) \[[@B56]\], it suffices to demonstrate that there exist some neighborhood *U* and a nonnegative *C*^2^-function *V* such that ∀*x* ∈ *𝔼*~*n*~∖*U*, *LV*(*x*) \< 0.

Using [Lemma 6](#lem4.1){ref-type="statement"}, we can get the following main results.

Theorem 8 .For any given initial value (*S*(0), *E*(0), *I*(0), *Q*(0), *R*(0)) ∈ *ℝ*~+~^5^. If$$\begin{matrix}
{\operatorname{}R^{\ast}} \\
{≔ \frac{\mu\left( {1 - \delta p} \right)\beta\alpha}{\left( {\delta p + \mu + {\sigma_{1}^{2}/2}} \right)\left( {\alpha + \mu + {\sigma_{2}^{2}/2}} \right)\left( {\lambda + \varepsilon_{1} + \gamma + \mu + {\sigma_{3}^{2}/2}} \right)}} \\
{ > 1} \\
\end{matrix}$$holds, then system ([5](#EEq3){ref-type="disp-formula"}) has a unique stationary distribution *π*(·) and it has ergodic property.

ProofDefine a *C*^2^-function $\left. \overset{¯}{V}:\mathbb{R}_{+}^{5}\rightarrow\mathbb{R} \right.$ by$$\begin{matrix}
{\operatorname{}\overset{¯}{V}\left( { S,E,I,Q,R} \right)} \\
{\mspace{1170mu} = \Upsilon\left( { S + E + I + Q + R - a_{1}{\ln S} - a_{2}{\ln E} - a_{3}{\ln I}} \right)} \\
{\mspace{3230mu} + \frac{1}{\varrho + 1}\left( { S + E + I + Q + R} \right)^{\varrho + 1} - {\ln S} - {\ln E}} \\
{\mspace{3230mu} - {\ln Q} - {\ln R} + \left( { S + E + I + Q + R} \right)} \\
{\mspace{1170mu} ≔ \Upsilon V_{1} + V_{2} + V_{3} + V_{4} + V_{5} + V_{6} + V_{7},} \\
\end{matrix}$$and here *ϱ* and *a*~*i*~  (*i* = 1,2, 3) are positive constants satisfying the following conditions: $$\begin{matrix}
{0\operatorname{} < \varrho < \frac{2\mu}{\sigma_{1}^{2} \vee \sigma_{2}^{2} \vee \sigma_{3}^{2} \vee \sigma_{4}^{2} \vee \sigma_{5}^{2}},} \\
 \\
{a_{1}\operatorname{} = \frac{\Lambda}{\delta p + \mu + {\sigma_{1}^{2}/2}},} \\
 \\
{a_{2}\operatorname{} = \frac{\Lambda}{\alpha + \mu + {\sigma_{2}^{2}/2}},} \\
 \\
{a_{3}\operatorname{} = \frac{\Lambda}{\lambda + \varepsilon_{1} + \gamma + \mu + {\sigma_{3}^{2}/2}},} \\
 \\
\end{matrix}$$and we take *Υ* \> 0 large enough such that $$\begin{matrix}
{- \Upsilon\phi + M \leq - 2;} \\
\end{matrix}$$here$$\begin{matrix}
{\phi\operatorname{} ≔ 4\Lambda\left\lbrack {\left\lbrack { R^{\ast}} \right\rbrack^{1/4} - 1} \right\rbrack,} \\
 \\
{M\operatorname{} ≔ \Lambda + \Gamma + \delta p + \alpha + \varphi + \varepsilon_{2} + 4\mu + \frac{\sigma_{1}^{2}}{2} + \frac{\sigma_{2}^{2}}{2} + \frac{\sigma_{4}^{2}}{2}} \\
{\mspace{2370mu} + \frac{\sigma_{5}^{2}}{2}.} \\
\end{matrix}$$Obviously, $$\begin{matrix}
{{\underset{w\rightarrow,{({S,E,I,Q,R})} \in \mathbb{R}_{+}^{5} \smallsetminus U_{w}}{\lim\,\inf}{\overset{¯}{V}\left( { S,E,I,Q,R} \right)}} = \infty,} \\
\end{matrix}$$and here *U*~*w*~ = (1/*w*, *w*) × (1/*w*, *w*) × (1/*w*, *w*) × (1/*w*, *w*) × (1/*w*, *w*). Since $\overset{¯}{V}(S,E,I,Q,R)$ is a continuous function, then there exists a unique point $(\underset{\_}{S^{\ast}},\underset{\_}{E^{\ast}},\underset{\_}{I^{\ast}},\underset{\_}{Q^{\ast}},\underset{\_}{R^{\ast}})$ in *ℝ*~+~^5^ which is the minimum point of $\overset{¯}{V}(S,E,I,Q,R)$. Therefore let us construct a positive-definite *C*^2^-function *V*: *ℝ*~+~^5^ → *ℝ*~+~ by $$\begin{matrix}
{V\left( { S,E,I,Q,R} \right) = \overset{¯}{V}\left( { S,E,I,Q,R} \right)} \\
{\mspace{2060mu} - \overset{¯}{V}\left( {\underset{\_}{S^{\ast}},\underset{\_}{E^{\ast}},\underset{\_}{I^{\ast}},\underset{\_}{Q^{\ast}},\underset{\_}{R^{\ast}}} \right).} \\
\end{matrix}$$From Itô\'s formula, we have$$\begin{matrix}
{\mathcal{L}V_{1} = - \mu\left( { S + E + I + Q + R} \right) - \frac{a_{1}\Lambda}{S} - \frac{a_{2}\left( {1 - \delta} \right)\beta SI}{E\left( {N - Q} \right)} - \frac{a_{2}\delta\left( {1 - p} \right)\beta SI}{E\left( {N - Q} \right)} - \frac{a_{3}\alpha E}{I} + \frac{a_{1}\left( {1 - \delta} \right)\beta I}{N - Q} + \frac{a_{1}\delta\left( {1 - p} \right)\beta I}{N - Q}} \\
{\mspace{2060mu} + \Lambda + a_{1}\left( {\delta p + \mu + \frac{\sigma_{1}^{2}}{2}} \right) + a_{2}\left( {\alpha + \mu + \frac{\sigma_{2}^{2}}{2}} \right) + a_{3}\left( {\lambda + \varepsilon_{1} + \gamma + \mu + \frac{\sigma_{3}^{2}}{2}} \right) - \varepsilon_{1}I - \varepsilon_{2}Q} \\
{\leq - \mu\left( { S + E + I + Q + R} \right) - \frac{a_{1}\Lambda}{S} - \frac{a_{2}\left( {1 - \delta p} \right)\beta SI}{E\left( {S + E + I + Q + R} \right)} - \frac{a_{3}\alpha E}{I} + \frac{a_{1}\left( {1 - \delta p} \right)\beta I}{S + E + I + R} + \Lambda + a_{1}\left( {\delta p + \mu + \frac{\sigma_{1}^{2}}{2}} \right)} \\
{\mspace{2060mu} + a_{2}\left( {\alpha + \mu + \frac{\sigma_{2}^{2}}{2}} \right) + a_{3}\left( {\lambda + \varepsilon_{1} + \gamma + \mu + \frac{\sigma_{3}^{2}}{2}} \right) \leq - 4\left( { a_{1}a_{2}a_{3}\Lambda\mu\left( { 1 - \delta p} \right)\beta\alpha} \right)^{1/4} + \frac{a_{1}\left( {1 - \delta p} \right)\beta I}{S + E + I + R} + 4\Lambda} \\
{= - 4\Lambda\left\lbrack {\left\lbrack {\frac{\mu\left( {1 - \delta p} \right)\beta\alpha}{\left\lbrack {\delta p + \mu + {\sigma_{1}^{2}/2}} \right\rbrack\left\lbrack {\alpha + \mu + {\sigma_{2}^{2}/2}} \right\rbrack\left\lbrack {\lambda + \varepsilon_{1} + \gamma + \mu + {\sigma_{3}^{2}/2}} \right\rbrack}} \right\rbrack^{1/4} - 1} \right\rbrack + \frac{a_{1}\left( {1 - \delta p} \right)\beta I}{S + E + I + R}} \\
{= - 4\Lambda\left\lbrack {\left\lbrack { R^{\ast}} \right\rbrack^{1/4} - 1} \right\rbrack + \frac{a_{1}\left( {1 - \delta p} \right)\beta I}{S + E + I + R} = - \phi + \frac{a_{1}\left( {1 - \delta p} \right)\beta I}{S + E + I + R}.} \\
\end{matrix}$$Similarly,$$\begin{matrix}
{\operatorname{}\mathcal{L}V_{2} = \left( { S + E + I + Q + R} \right)^{\varrho}} \\
{\mspace{1800mu} \cdot \left\lbrack {\Lambda - \mu\left\lbrack { S + E + I + Q + R} \right\rbrack - \varepsilon_{1}I - \varepsilon_{2}Q} \right\rbrack} \\
{\mspace{1800mu} + \frac{\varrho\left( {S + E + I + Q + R} \right)^{\varrho - 1}}{2}} \\
{\mspace{1800mu} \times \left( {\sigma_{1}^{2}S^{2} + \sigma_{2}^{2}E^{2} + \sigma_{3}^{2}I^{2} + \sigma_{4}^{2}Q^{2} + \sigma_{5}^{2}R^{2}} \right)} \\
{\mspace{1800mu} \leq \Lambda\left( { S + E + I + Q + R} \right)^{\varrho}} \\
{\mspace{1800mu} - \left\lbrack {\mu - \frac{\varrho}{2}\left\lbrack {\sigma_{1}^{2} \vee \sigma_{2}^{2} \vee \sigma_{3}^{2} \vee \sigma_{4}^{2} \vee \sigma_{5}^{2}} \right\rbrack} \right\rbrack} \\
{\mspace{1800mu} \cdot \left( { S + E + I + Q + R} \right)^{\varrho + 1} \leq \Gamma} \\
{\mspace{1800mu} - \frac{1}{2}\left\lbrack {\mu - \frac{\varrho}{2}\left\lbrack {\sigma_{1}^{2} \vee \sigma_{2}^{2} \vee \sigma_{3}^{2} \vee \sigma_{4}^{2} \vee \sigma_{5}^{2}} \right\rbrack} \right\rbrack} \\
{\mspace{1800mu} \cdot \left( { S + E + I + Q + R} \right)^{\varrho + 1} \leq \Gamma} \\
{\mspace{1800mu} - \frac{1}{2}\left\lbrack {\mu - \frac{\varrho}{2}\left\lbrack {\sigma_{1}^{2} \vee \sigma_{2}^{2} \vee \sigma_{3}^{2} \vee \sigma_{4}^{2} \vee \sigma_{5}^{2}} \right\rbrack} \right\rbrack} \\
{\mspace{1800mu} \cdot \left( { S^{\varrho + 1} + E^{\varrho + 1} + I^{\varrho + 1} + Q^{\varrho + 1} + R^{\varrho + 1}} \right),} \\
\end{matrix}$$and here$$\begin{matrix}
{\Gamma = {\sup\limits_{{({S,E,I,Q,R})} \in \mathbb{R}_{+}^{5}}\left\{ {\Lambda\left\{ { S + E + I + Q + R} \right\}^{\varrho}\mspace{1800mu} - \frac{1}{2}\left\lbrack {\mu - \frac{\varrho}{2}\left\lbrack {\sigma_{1}^{2} \vee \sigma_{2}^{2} \vee \sigma_{3}^{2} \vee \sigma_{4}^{2} \vee \sigma_{5}^{2}} \right\rbrack} \right\rbrack\mspace{1800mu} \times \left\{ { S + E + I + Q + R} \right\}^{\varrho + 1}} \right\}} < \infty.} \\
\end{matrix}$$We also have$$\begin{matrix}
{\mathcal{L}V_{3}\operatorname{} = - \frac{\Lambda}{S} + \frac{\left( {1 - \delta p} \right)\beta I}{S + E + I + R} + \delta p + \mu + \frac{\sigma_{1}^{2}}{2},} \\
 \\
{\mathcal{L}V_{4}\operatorname{} \leq - \frac{\left( {1 - \delta p} \right)\beta SI}{E\left( {S + E + I + Q + R} \right)} + \alpha + \mu + \frac{\sigma_{2}^{2}}{2},} \\
 \\
{\mathcal{L}V_{5}\operatorname{} = - \frac{\lambda I}{Q} + \varphi + \varepsilon_{2} + \mu + \frac{\sigma_{4}^{2}}{2},} \\
 \\
{\mathcal{L}V_{6}\operatorname{} = - \frac{\delta pS + \gamma I + \varphi Q}{R} + \mu + \frac{\sigma_{5}^{2}}{2},} \\
 \\
{\mathcal{L}V_{7}\operatorname{} \leq \Lambda - \mu\left( { S + E + I + Q + R} \right).} \\
 \\
\end{matrix}$$Therefore,$$\begin{matrix}
{\operatorname{}\mathcal{L}V \leq - \Upsilon\phi + \frac{\Upsilon a_{1}\left( {1 - \delta p} \right)\beta I}{S + E + I + R} + \frac{\left( {1 - \delta p} \right)\beta I}{S + E + I + R}} \\
{\mspace{1800mu} - \frac{1}{2}\left\lbrack {\mu - \frac{\varrho}{2}\left\lbrack {\sigma_{1}^{2} \vee \sigma_{2}^{2} \vee \sigma_{3}^{2} \vee \sigma_{4}^{2} \vee \sigma_{5}^{2}} \right\rbrack} \right\rbrack} \\
{\mspace{1800mu} \times \left( { S^{\varrho + 1} + E^{\varrho + 1} + I^{\varrho + 1} + Q^{\varrho + 1} + R^{\varrho + 1}} \right) - \frac{\Lambda}{S}} \\
{\mspace{1800mu} - \frac{\left( {1 - \delta p} \right)\beta SI}{E\left( {S + E + I + Q + R} \right)} - \mu\left( { S + E + I + Q + R} \right)} \\
{\mspace{1800mu} - \frac{\lambda I}{Q} - \frac{\delta pS + \gamma I + \varphi Q}{R} + \Lambda + \Gamma + \delta p + \alpha + \varphi + \varepsilon_{2}} \\
{\mspace{1800mu} + 4\mu + \frac{\sigma_{1}^{2}}{2} + \frac{\sigma_{2}^{2}}{2} + \frac{\sigma_{4}^{2}}{2} + \frac{\sigma_{5}^{2}}{2} \leq - \Upsilon\phi} \\
{\mspace{1800mu} + \frac{\left( {\Upsilon a_{1} + 1} \right)\left( {1 - \delta p} \right)\beta I}{S + E + I + R}} \\
{\mspace{1800mu} - \frac{1}{2}\left\lbrack {\mu - \frac{\varrho}{2}\left\lbrack {\sigma_{1}^{2} \vee \sigma_{2}^{2} \vee \sigma_{3}^{2} \vee \sigma_{4}^{2} \vee \sigma_{5}^{2}} \right\rbrack} \right\rbrack} \\
{\mspace{1800mu} \cdot \left( { S^{\varrho + 1} + E^{\varrho + 1} + I^{\varrho + 1} + Q^{\varrho + 1} + R^{\varrho + 1}} \right) - \frac{\Lambda}{S}} \\
{\mspace{1800mu} - 2\left( {\frac{\mu\left( {1 - \delta p} \right)\beta SI}{E}} \right)^{1/2} - \frac{\lambda I}{Q} - \frac{\delta pS + \gamma I + \varphi Q}{R}} \\
{\mspace{1800mu} + M,} \\
\end{matrix}$$where *M* = Λ + Γ + *δp* + *α* + *φ* + *ε*~2~ + 4*μ* + *σ*~1~^2^/2 + *σ*~2~^2^/2 + *σ*~4~^2^/2 + *σ*~5~^2^/2.Next let us consider the following compact subset *D*: $$\begin{matrix}
{D = \left\{ {\epsilon \leq S \leq \frac{1}{\epsilon},\epsilon^{4} \leq E \leq \frac{1}{\epsilon^{4}},\epsilon^{2} \leq I \leq \frac{1}{\epsilon^{2}},\epsilon^{3} \leq Q\mspace{1800mu} \leq \frac{1}{\epsilon^{3}},\epsilon^{4} \leq R \leq \frac{1}{\epsilon^{4}}} \right\},} \\
\end{matrix}$$and here *ϵ* is a sufficiently small constant satisfying the following conditions:$$\begin{matrix}
{- \frac{\Lambda}{\epsilon} + \left( {\Upsilon a_{1} + 1} \right)\left( { 1 - \delta p} \right)\beta + M \leq - 1,} \\
\end{matrix}$$$$\begin{matrix}
{\operatorname{} - 2\left( {\frac{\mu\left( {1 - \delta p} \right)\beta}{\epsilon}} \right)^{1/2} + \left( {\Upsilon a_{1} + 1} \right)\left( { 1 - \delta p} \right)\beta} \\
{\mspace{1800mu} + M \leq - 1,} \\
\end{matrix}$$$$\begin{matrix}
{- \Upsilon\phi + \left( {\Upsilon a_{1} + 1} \right)\left( { 1 - \delta p} \right)\beta\epsilon + M \leq - 1,} \\
\end{matrix}$$$$\begin{matrix}
{- \frac{\lambda}{\epsilon} + \left( {\Upsilon a_{1} + 1} \right)\left( { 1 - \delta p} \right)\beta + M \leq - 1,} \\
\end{matrix}$$$$\begin{matrix}
{- \frac{\delta p}{\epsilon^{3}} - \frac{\gamma}{\epsilon^{2}} - \frac{\varphi}{\epsilon} + \left( {\Upsilon a_{1} + 1} \right)\left( { 1 - \delta p} \right)\beta + M \leq - 1,} \\
\end{matrix}$$$$\begin{matrix}
{\operatorname{} - \frac{1}{2}\left\lbrack {\mu - \frac{\varrho}{2}\left\lbrack {\sigma_{1}^{2} \vee \sigma_{2}^{2} \vee \sigma_{3}^{2} \vee \sigma_{4}^{2} \vee \sigma_{5}^{2}} \right\rbrack} \right\rbrack\frac{1}{\epsilon^{\varrho + 1}}} \\
{\mspace{1800mu} + \left( {\Upsilon a_{1} + 1} \right)\left( { 1 - \delta p} \right)\beta + M \leq - 1,} \\
\end{matrix}$$$$\begin{matrix}
{\operatorname{} - \frac{1}{2}\left\lbrack {\mu - \frac{\varrho}{2}\left\lbrack {\sigma_{1}^{2} \vee \sigma_{2}^{2} \vee \sigma_{3}^{2} \vee \sigma_{4}^{2} \vee \sigma_{5}^{2}} \right\rbrack} \right\rbrack\frac{1}{\epsilon^{4{({\varrho + 1})}}}} \\
{\mspace{1800mu} + \left( {\Upsilon a_{1} + 1} \right)\left( { 1 - \delta p} \right)\beta + M \leq - 1,} \\
\end{matrix}$$$$\begin{matrix}
{\operatorname{} - \frac{1}{2}\left\lbrack {\mu - \frac{\varrho}{2}\left\lbrack {\sigma_{1}^{2} \vee \sigma_{2}^{2} \vee \sigma_{3}^{2} \vee \sigma_{4}^{2} \vee \sigma_{5}^{2}} \right\rbrack} \right\rbrack\frac{1}{\epsilon^{2{({\varrho + 1})}}}} \\
{\mspace{1800mu} + \left( {\Upsilon a_{1} + 1} \right)\left( { 1 - \delta p} \right)\beta + M \leq - 1,} \\
\end{matrix}$$$$\begin{matrix}
{\operatorname{} - \frac{1}{2}\left\lbrack {\mu - \frac{\varrho}{2}\left\lbrack {\sigma_{1}^{2} \vee \sigma_{2}^{2} \vee \sigma_{3}^{2} \vee \sigma_{4}^{2} \vee \sigma_{5}^{2}} \right\rbrack} \right\rbrack\frac{1}{\epsilon^{3{({\varrho + 1})}}}} \\
{\mspace{1800mu} + \left( {\Upsilon a_{1} + 1} \right)\left( { 1 - \delta p} \right)\beta + M \leq - 1.} \\
\end{matrix}$$Then$$\begin{matrix}
{\mathbb{R}_{+}^{5} \smallsetminus D = D_{1} \cup D_{2} \cup D_{3} \cup D_{4} \cup D_{5} \cup D_{6} \cup D_{7} \cup D_{8}} \\
{\mspace{2060mu} \cup D_{9} \cup D_{10},} \\
\end{matrix}$$with$$\begin{matrix}
{D_{1} = \left\{ {\left( { S,E,I,Q,R} \right) \in \mathbb{R}_{+}^{5}{\, \mid \,}0 < S < \epsilon} \right\},} \\
{D_{2} = \left\{ {\left( { S,E,I,Q,R} \right) \in \mathbb{R}_{+}^{5}{\, \mid \,}S \geq \epsilon,I \geq \epsilon^{2},0 < E < \epsilon^{4}} \right\},} \\
{D_{3} = \left\{ {\left( { S,E,I,Q,R} \right) \in \mathbb{R}_{+}^{5}{\, \mid \,}S \geq \epsilon,0 < I < \epsilon^{2}} \right\},} \\
{D_{4} = \left\{ {\left( { S,E,I,Q,R} \right) \in \mathbb{R}_{+}^{5}{\, \mid \,}I \geq \epsilon^{2},0 < Q < \epsilon^{3}} \right\},} \\
{D_{5} = \left\{ {\left( { S,E,I,Q,R} \right) \in \mathbb{R}_{+}^{5}{\, \mid \,}S \geq \epsilon,I \geq \epsilon^{2},Q \geq \epsilon^{3},0 < R\mspace{1800mu} < \epsilon^{4}} \right\},} \\
{D_{6} = \left\{ {\left( { S,E,I,Q,R} \right) \in \mathbb{R}_{+}^{5}{\, \mid \,}S > \frac{1}{\epsilon}} \right\},} \\
{D_{7} = \left\{ {\left( { S,E,I,Q,R} \right) \in \mathbb{R}_{+}^{5}{\, \mid \,}E > \frac{1}{\epsilon^{4}}} \right\},} \\
{D_{8} = \left\{ {\left( { S,E,I,Q,R} \right) \in \mathbb{R}_{+}^{5}{\, \mid \,}I > \frac{1}{\epsilon^{2}}} \right\},} \\
{D_{9} = \left\{ {\left( { S,E,I,Q,R} \right) \in \mathbb{R}_{+}^{5}{\, \mid \,}Q > \frac{1}{\epsilon^{3}}} \right\},} \\
{D_{10} = \left\{ {\left( { S,E,I,Q,R} \right) \in \mathbb{R}_{+}^{5}{\, \mid \,}R > \frac{1}{\epsilon^{4}}} \right\}.} \\
\end{matrix}$$Now we analyze the negativity of *ℒV* for any (S, *E*, *I*, *Q*, *R*) ∈ *ℝ*~+~^5^∖*D*.*Case I*. If (*S*, *I*, *Q*, *R*) ∈ *D*~1~, ([46](#EEq11){ref-type="disp-formula"}) and ([48](#EEq12){ref-type="disp-formula"}) derive that $$\begin{matrix}
{\mathcal{L}V \leq - \frac{\Lambda}{S} + \frac{\left( {\Upsilon a_{1} + 1} \right)\left( {1 - \delta p} \right)\beta I}{S + E + I + R} + M} \\
{\leq - \frac{\Lambda}{\epsilon} + \left( {\Upsilon a_{1} + 1} \right)\left( { 1 - \delta p} \right)\beta + M \leq - 1.} \\
\end{matrix}$$*Case II*. If (*S*, *I*, *Q*, *R*) ∈ *D*~2~, ([46](#EEq11){ref-type="disp-formula"}) and ([49](#EEq13){ref-type="disp-formula"}) imply that $$\begin{matrix}
{\mathcal{L}V \leq - 2\left( {\frac{\mu\left( {1 - \delta p} \right)\beta SI}{E}} \right)^{1/2}} \\
{\mspace{2060mu} + \frac{\left( {\Upsilon a_{1} + 1} \right)\left( {1 - \delta p} \right)\beta I}{S + E + I + R} + M} \\
{\leq - 2\left( {\frac{\mu\left( {1 - \delta p} \right)\beta}{\epsilon}} \right)^{1/2} + \left( {\Upsilon a_{1} + 1} \right)\left( { 1 - \delta p} \right)\beta} \\
{\mspace{2060mu} + M \leq - 1.} \\
\end{matrix}$$*Case III*. If (*S*, *I*, *Q*, *R*) ∈ *D*~3~, it follows from ([46](#EEq11){ref-type="disp-formula"}) and ([50](#EEq14){ref-type="disp-formula"}) that$$\begin{matrix}
{\mathcal{L}V \leq - \Upsilon\phi + \frac{\left( {\Upsilon a_{1} + 1} \right)\left( {1 - \delta p} \right)\beta I}{S + E + I + R} + M} \\
{\leq - \Upsilon\phi + \frac{\left( {\Upsilon a_{1} + 1} \right)\left( {1 - \delta p} \right)\beta I}{S} + M} \\
{\leq - \Upsilon\phi + \left( {\Upsilon a_{1} + 1} \right)\left( { 1 - \delta p} \right)\beta\epsilon + M \leq - 1.} \\
\end{matrix}$$*Case IV*. If (*S*, *I*, *Q*, *R*) ∈ *D*~4~, ([46](#EEq11){ref-type="disp-formula"}) and ([51](#EEq15){ref-type="disp-formula"}) yield that $$\begin{matrix}
{\mathcal{L}V \leq - \frac{\lambda I}{Q} + \frac{\left( {\Upsilon a_{1} + 1} \right)\left( {1 - \delta p} \right)\beta I}{S + E + I + R} + M} \\
{\leq - \frac{\lambda}{\epsilon} + \left( {\Upsilon a_{1} + 1} \right)\left( { 1 - \delta p} \right)\beta + M \leq - 1.} \\
\end{matrix}$$*Case V*. If (*S*, *I*, *Q*, *R*) ∈ *D*~5~, it follows from ([46](#EEq11){ref-type="disp-formula"}) and ([52](#EEq16){ref-type="disp-formula"}) that$$\begin{matrix}
{\mathcal{L}V \leq - \frac{\delta pS + \gamma I + \varphi Q}{R} + \frac{\left( {\Upsilon a_{1} + 1} \right)\left( {1 - \delta p} \right)\beta I}{S + E + I + R}} \\
{\mspace{2060mu} + M} \\
{\leq - \frac{\delta p}{\epsilon^{3}} - \frac{\gamma}{\epsilon^{2}} - \frac{\varphi}{\epsilon} + \left( {\Upsilon a_{1} + 1} \right)\left( { 1 - \delta p} \right)\beta + M} \\
{\leq - 1.} \\
\end{matrix}$$*Case VI*. If (*S*, *I*, *Q*, *R*) ∈ *D*~6~, ([46](#EEq11){ref-type="disp-formula"}) and ([53](#EEq17){ref-type="disp-formula"}) lead to$$\begin{matrix}
{\mathcal{L}V \leq - \frac{1}{2}\left\lbrack {\mu - \frac{\varrho}{2}\left\lbrack {\sigma_{1}^{2} \vee \sigma_{2}^{2} \vee \sigma_{3}^{2} \vee \sigma_{4}^{2} \vee \sigma_{5}^{2}} \right\rbrack} \right\rbrack S^{\varrho + 1}} \\
{\mspace{2060mu} + \frac{\left( {\Upsilon a_{1} + 1} \right)\left( {1 - \delta p} \right)\beta I}{S + E + I + R} + M} \\
{\leq - \frac{1}{2}\left\lbrack {\mu - \frac{\varrho}{2}\left\lbrack {\sigma_{1}^{2} \vee \sigma_{2}^{2} \vee \sigma_{3}^{2} \vee \sigma_{4}^{2} \vee \sigma_{5}^{2}} \right\rbrack} \right\rbrack\frac{1}{\epsilon^{\varrho + 1}}} \\
{\mspace{2060mu} + \left( {\Upsilon a_{1} + 1} \right)\left( { 1 - \delta p} \right)\beta + M \leq - 1.} \\
\end{matrix}$$*Case VII*. If (*S*, *I*, *Q*, *R*) ∈ *D*~7~, ([46](#EEq11){ref-type="disp-formula"}) and ([54](#EEq18){ref-type="disp-formula"}) derive that$$\begin{matrix}
{\mathcal{L}V \leq - \frac{1}{2}\left\lbrack {\mu - \frac{\varrho}{2}\left\lbrack {\sigma_{1}^{2} \vee \sigma_{2}^{2} \vee \sigma_{3}^{2} \vee \sigma_{4}^{2} \vee \sigma_{5}^{2}} \right\rbrack} \right\rbrack E^{\varrho + 1}} \\
{\mspace{2060mu} + \frac{\left( {\Upsilon a_{1} + 1} \right)\left( {1 - \delta p} \right)\beta I}{S + E + I + R} + M} \\
{\leq - \frac{1}{2}\left\lbrack {\mu - \frac{\varrho}{2}\left\lbrack {\sigma_{1}^{2} \vee \sigma_{2}^{2} \vee \sigma_{3}^{2} \vee \sigma_{4}^{2} \vee \sigma_{5}^{2}} \right\rbrack} \right\rbrack\frac{1}{\epsilon^{4{({\varrho + 1})}}}} \\
{\mspace{2060mu} + \left( {\Upsilon a_{1} + 1} \right)\left( { 1 - \delta p} \right)\beta + M \leq - 1.} \\
\end{matrix}$$*Case VIII*. If (*S*, *I*, *Q*, *R*) ∈ *D*~8~, it follows from ([46](#EEq11){ref-type="disp-formula"}) and ([55](#EEq19){ref-type="disp-formula"}) that $$\begin{matrix}
{\mathcal{L}V \leq - \frac{1}{2}\left\lbrack {\mu - \frac{\varrho}{2}\left\lbrack {\sigma_{1}^{2} \vee \sigma_{2}^{2} \vee \sigma_{3}^{2} \vee \sigma_{4}^{2} \vee \sigma_{5}^{2}} \right\rbrack} \right\rbrack I^{\varrho + 1}} \\
{\mspace{2060mu} + \frac{\left( {\Upsilon a_{1} + 1} \right)\left( {1 - \delta p} \right)\beta I}{S + E + I + R} + M} \\
{\leq - \frac{1}{2}\left\lbrack {\mu - \frac{\varrho}{2}\left\lbrack {\sigma_{1}^{2} \vee \sigma_{2}^{2} \vee \sigma_{3}^{2} \vee \sigma_{4}^{2} \vee \sigma_{5}^{2}} \right\rbrack} \right\rbrack\frac{1}{\epsilon^{2{({\varrho + 1})}}}} \\
{\mspace{2060mu} + \left( {\Upsilon a_{1} + 1} \right)\left( { 1 - \delta p} \right)\beta + M \leq - 1.} \\
\end{matrix}$$*Case IX*. If (*S*, *I*, *Q*, *R*) ∈ *D*~9~, ([46](#EEq11){ref-type="disp-formula"}) and ([56](#EEq20){ref-type="disp-formula"}) derive that$$\begin{matrix}
{\mathcal{L}V \leq - \frac{1}{2}\left\lbrack {\mu - \frac{\varrho}{2}\left\lbrack {\sigma_{1}^{2} \vee \sigma_{2}^{2} \vee \sigma_{3}^{2} \vee \sigma_{4}^{2} \vee \sigma_{5}^{2}} \right\rbrack} \right\rbrack Q^{\varrho + 1}} \\
{\mspace{2060mu} + \frac{\left( {\Upsilon a_{1} + 1} \right)\left( {1 - \delta p} \right)\beta I}{S + E + I + R} + M} \\
{\leq - \frac{1}{2}\left\lbrack {\mu - \frac{\varrho}{2}\left\lbrack {\sigma_{1}^{2} \vee \sigma_{2}^{2} \vee \sigma_{3}^{2} \vee \sigma_{4}^{2} \vee \sigma_{5}^{2}} \right\rbrack} \right\rbrack\frac{1}{\epsilon^{3{({\varrho + 1})}}}} \\
{\mspace{2060mu} + \left( {\Upsilon a_{1} + 1} \right)\left( { 1 - \delta p} \right)\beta + M \leq - 1.} \\
\end{matrix}$$*Case X*. If (*S*, *I*, *Q*, *R*) ∈ *D*~10~, it follows from ([46](#EEq11){ref-type="disp-formula"}) and ([54](#EEq18){ref-type="disp-formula"}) that$$\begin{matrix}
{\mathcal{L}V \leq - \frac{1}{2}\left\lbrack {\mu - \frac{\varrho}{2}\left\lbrack {\sigma_{1}^{2} \vee \sigma_{2}^{2} \vee \sigma_{3}^{2} \vee \sigma_{4}^{2} \vee \sigma_{5}^{2}} \right\rbrack} \right\rbrack R^{\varrho + 1}} \\
{\mspace{2060mu} + \frac{\left( {\Upsilon a_{1} + 1} \right)\left( {1 - \delta p} \right)\beta I}{S + E + I + R} + M} \\
{\leq - \frac{1}{2}\left\lbrack {\mu - \frac{\varrho}{2}\left\lbrack {\sigma_{1}^{2} \vee \sigma_{2}^{2} \vee \sigma_{3}^{2} \vee \sigma_{4}^{2} \vee \sigma_{5}^{2}} \right\rbrack} \right\rbrack\frac{1}{\epsilon^{4{({\varrho + 1})}}}} \\
{\mspace{2060mu} + \left( {\Upsilon a_{1} + 1} \right)\left( { 1 - \delta p} \right)\beta + M \leq - 1.} \\
\end{matrix}$$Clearly, from the discussion of the above ten cases, one sees that, for a sufficiently small *ϵ*, $$\begin{matrix}
{\mathcal{L}V \leq - 1\mspace{1800mu}\forall\left( {S,E,I,Q,R} \right) \in \mathbb{R}_{+}^{5} \smallsetminus D,} \\
\end{matrix}$$which shows that [Assumption 5](#assump4.1){ref-type="statement"}(ii) is satisfied. In addition, the diffusion matrix of system ([5](#EEq3){ref-type="disp-formula"}) takes the following form:$$\begin{matrix}
{\overset{\sim}{A} = \begin{pmatrix}
{\sigma_{1}^{2}S^{2}} & 0 & 0 & 0 & 0 \\
0 & {\sigma_{2}^{2}E^{2}} & 0 & 0 & 0 \\
0 & 0 & {\sigma_{3}^{2}I^{2}} & 0 & 0 \\
0 & 0 & 0 & {\sigma_{4}^{2}Q^{2}} & 0 \\
0 & 0 & 0 & 0 & {\sigma_{5}^{2}R^{2}} \\
\end{pmatrix}.} \\
\end{matrix}$$There exists a positive number$$\begin{matrix}
{Z = {\min\limits_{{({S,E,I,Q,R})} \in \overset{¯}{D}}\left\{ {\sigma_{1}^{2}S^{2},\sigma_{2}^{2}E^{2},\sigma_{3}^{2}I^{2},\sigma_{4}^{2}Q^{2},\sigma_{5}^{2}R^{2}} \right\}}} \\
\end{matrix}$$such that$$\begin{matrix}
{{\sum\limits_{i,j = 1}^{5}{a_{ij}\xi_{i}\xi_{j}}} = \sigma_{1}^{2}S^{2}\xi_{1}^{2} + \sigma_{2}^{2}E^{2}\xi_{2}^{2} + \sigma_{3}^{2}I^{2}\xi_{3}^{2} + \sigma_{4}^{2}Q^{2}\xi_{4}^{2}} \\
{\mspace{2060mu} + \sigma_{5}^{2}R^{2}\xi_{5}^{2} \geq Z\left| {\xi} \right|^{2},} \\
{\mspace{11820mu}\left( {S,E,I,Q,R} \right) \in \overset{¯}{D},\text{  }\xi \in \mathbb{R}^{5},} \\
\end{matrix}$$which shows that [Assumption 5](#assump4.1){ref-type="statement"}(i) is satisfied. Consequently, system ([5](#EEq3){ref-type="disp-formula"}) has a unique stationary distribution *π*(·) and it has ergodic property. The proof of [Theorem 8](#thm4.1){ref-type="statement"} is complete.

Remark 9 .From [Theorem 8](#thm4.1){ref-type="statement"}, we see that if *R*^*∗*^ \> 1 holds, then system ([5](#EEq3){ref-type="disp-formula"}) has a unique ergodic stationary distribution. It is worthwhile noting that if *σ*~*i*~ = 0  (*i* = 1,2, 3,4, 5), the expression of *R*^*∗*^ coincides with the basic reproduction number *R*~1~ of system ([3](#EEq2){ref-type="disp-formula"}). This shows that we generalize the results of system ([3](#EEq2){ref-type="disp-formula"}). For another, this theorem also shows that the disease can resist a small environmental noise to maintain the original persistence.

5. Conclusions and Simulations {#sec5}
==============================

This paper studies the stochastic SEIQR epidemic model with quarantine-adjusted incidence and imperfect vaccination and obtains two thresholds which govern the extinction and the spread of the epidemic disease. Firstly, the existence of a unique positive solution of system ([5](#EEq3){ref-type="disp-formula"}) with any positive initial value is proved. Then, from Theorems [4](#thm3.1){ref-type="statement"} and [8](#thm4.1){ref-type="statement"}, the sufficient conditions for extinction of the disease and existence of ergodic stationary distribution of the stochastic system are derived by using the theory of Hasminskii and the Lyapunov analysis methods, which means the infectious disease is prevalent. This implies that the stochastic disturbance is conducive to epidemic diseases control. Now we summarize the main conclusions as follows:When *μ* \> (1/2)(*σ*~1~^2^∨*σ*~2~^2^∨*σ*~3~^2^∨*σ*~4~^2^∨*σ*~5~^2^) and ${\overset{\sim}{R}}^{\ast} = {\left( {2\alpha(1 - \delta p)\beta(\alpha + \mu)} \right)/\left( {\left( {\lambda + \varepsilon_{1} + \gamma + \mu + {\sigma_{3}^{2}/2}} \right)(\alpha + \mu)^{2} \land \left( {{\alpha^{2}\sigma_{2}^{2}}/2} \right)} \right)} < 1$ hold, then the infected individuals go to extinction almost surely.When *R*^*∗*^ = (*μ*(1 − *δp*)*βα*)/((*δp* + *μ* + *σ*~1~^2^/2)(*α* + *μ* + *σ*~2~^2^/2)(*λ* + *ε*~1~ + *γ* + *μ* + *σ*~3~^2^/2)) \> 1 holds, then system ([5](#EEq3){ref-type="disp-formula"}) has a unique stationary distribution *π*(·) and it has ergodic property.

To illustrate the results of the above theorems, we next carry out some numerical simulations by the Matlab software. Let us consider the following discretization equations of system ([5](#EEq3){ref-type="disp-formula"}):$$\begin{matrix}
{\operatorname{}S_{k + 1} = S_{k} + \left\lbrack {\Lambda - \frac{\left\lbrack {1 - \delta} \right\rbrack\beta S_{k}I_{k}}{S_{k} + E_{k} + I_{k} + R_{k}}\mspace{1800mu} - \frac{\delta\left\lbrack {1 - p} \right\rbrack\beta S_{k}I_{k}}{S_{k} + E_{k} + I_{k} + R_{k}} - \left\lbrack {\delta p + \mu} \right\rbrack S_{k}} \right\rbrack\Delta t} \\
{\mspace{1800mu} + \sigma_{1}S_{k}\sqrt{\Delta t}\zeta_{1,k} + \frac{\sigma_{1}^{2}}{2}S_{k}\left( {\zeta_{1,k}^{2} - 1} \right)\Delta t,} \\
{\operatorname{}E_{k + 1} = E_{k} + \left\lbrack {\frac{\left( {1 - \delta} \right)\beta S_{k}I_{k}}{S_{k} + E_{k} + I_{k} + R_{k}} + \frac{\delta\left( {1 - p} \right)\beta S_{k}I_{k}}{S_{k} + E_{k} + I_{k} + R_{k}}\mspace{1800mu} - \left( {\alpha + \mu} \right)E_{k}} \right\rbrack\Delta t + \sigma_{2}E_{k}\sqrt{\Delta t}\zeta_{2,k} + \frac{\sigma_{2}^{2}}{2}E_{k}\left( {\zeta_{2,k}^{2} - 1} \right)} \\
{\mspace{1800mu} \cdot \Delta t,} \\
{\operatorname{}I_{k + 1} = I_{k} + \left\lbrack {\alpha E_{k} - \left( {\lambda + \varepsilon_{1} + \gamma + \mu} \right)I_{k}} \right\rbrack\Delta t} \\
{\mspace{1800mu} + \sigma_{3}I_{k}\sqrt{\Delta t}\zeta_{3,k} + \frac{\sigma_{3}^{2}}{2}I_{k}\left( {\zeta_{3,k}^{2} - 1} \right)\Delta t,} \\
{\operatorname{}Q_{k + 1} = Q_{k} + \left\lbrack {\lambda I_{k} - \left( {\varphi + \varepsilon_{2} + \mu} \right)Q_{k}} \right\rbrack\Delta t} \\
{\mspace{1800mu} + \sigma_{4}Q_{k}\sqrt{\Delta t}\zeta_{4,k} + \frac{\sigma_{4}^{2}}{2}Q_{k}\left( {\zeta_{4,k}^{2} - 1} \right)\Delta t,} \\
{\operatorname{}R_{k + 1} = R_{k} + \left( {\delta pS_{k} + \gamma I_{k} + \varphi Q_{k} - \mu R_{k}} \right)\Delta t} \\
{\mspace{1800mu} + \sigma_{5}R_{k}\sqrt{\Delta t}\zeta_{5,k} + \frac{\sigma_{5}^{2}}{2}R_{k}\left( {\zeta_{5,k}^{2} - 1} \right)\Delta t,} \\
\end{matrix}$$and here *ζ*~*i*,*k*~  (*i* = 1,2, 3,4, 5; *k* = 1,2,..., *n*) stands for *N*(0,1) distributed independent random variables and time increment Δ*t* \> 0.

In [Figure 1](#fig1){ref-type="fig"}, take *S*(0) = *E*(0) = *I*(0) = *Q*(0) = *R*(0) = 0.3, Λ = 2, *μ* = 0.55, *β* = 0.25, *γ* = 0.2, *α* = 2.5, *δ* = 0.5, *p* = 0.5, *ε*~1~ = 0.1, *ε*~2~ = 0.1, *λ* = 0.18, *φ* = 0.15, *σ*~1~ = 0.15, *σ*~2~ = 1, *σ*~3~ = 1, *σ*~4~ = 0.5, *σ*~5~ = 0.25, and Δ*t* = 0.01. Then$$\begin{matrix}
{\mu = 0.55 > \frac{1}{2}\left( {\sigma_{1}^{2} \vee \sigma_{2}^{2} \vee \sigma_{3}^{2} \vee \sigma_{4}^{2} \vee \sigma_{5}^{2}} \right) = 0.5,} \\
 \\
{{\overset{\sim}{R}}^{\ast} = \frac{2\alpha\left( {1 - \delta p} \right)\beta\left( {\alpha + \mu} \right)}{\left( {\lambda + \varepsilon_{1} + \gamma + \mu + {\sigma_{3}^{2}/2}} \right)\left( {\alpha + \mu} \right)^{2} \land \left( {{\alpha^{2}\sigma_{2}^{2}}/2} \right)}} \\
{= 0.9150 < 1} \\
\end{matrix}$$satisfy the conditions in [Theorem 4](#thm3.1){ref-type="statement"}; we can obtain that the exposed, infected, and quarantined individuals go to extinction almost surely. Moreover,$$\begin{matrix}
{{\lim\limits_{t\rightarrow\infty}\left\langle { S} \right\rangle}\operatorname{} = \frac{\Lambda}{\delta p + \mu} = 2.5,} \\
 \\
{{\lim\limits_{t\rightarrow\infty}\left\langle { R} \right\rangle}\operatorname{} = \frac{\delta p\Lambda}{\mu\left( {\delta p + \mu} \right)} = 1.1364} \\
 \\
{\mspace{16680mu}\text{a.s.}} \\
\end{matrix}$$Obviously, [Figure 1](#fig1){ref-type="fig"} supports our results of [Theorem 4](#thm3.1){ref-type="statement"}.

In [Figure 2](#fig2){ref-type="fig"}, take *S*(0) = *E*(0) = *I*(0) = *Q*(0) = *R*(0) = 0.5, Λ = 0.3, *μ* = 0.1, *β* = 1.5, *γ* = 0.2, *α* = 0.3, *δ* = 0.1, *p* = 0.2, *ε*~1~ = 0.05, *ε*~2~ = 0.05, *λ* = 0.18, *φ* = 0.15, *σ*~1~ = *σ*~2~ = *σ*~3~ = *σ*~4~ = *σ*~5~ = 0.03, and Δ*t* = 0.01. Then $$\begin{matrix}
{\operatorname{}R^{\ast}} \\
{= \frac{\mu\left( {1 - \delta p} \right)\beta\alpha}{\left( {\delta p + \mu + {\sigma_{1}^{2}/2}} \right)\left( {\alpha + \mu + {\sigma_{2}^{2}/2}} \right)\left( {\lambda + \varepsilon_{1} + \gamma + \mu + {\sigma_{3}^{2}/2}} \right)}} \\
{ = 1.7236 > 1} \\
\end{matrix}$$satisfies the condition in [Theorem 8](#thm4.1){ref-type="statement"}; we can obtain that system ([5](#EEq3){ref-type="disp-formula"}) has a unique stationary distribution *π*(·) and it has ergodic property. [Figure 2](#fig2){ref-type="fig"} shows that the solution of system ([5](#EEq3){ref-type="disp-formula"}) swings up and down in a small neighborhood. According to the density functions in Figures [2(b)](#fig2){ref-type="fig"}--[2(f)](#fig2){ref-type="fig"}, we can see that there exists a stationary distribution. As expected, [Figure 2](#fig2){ref-type="fig"} confirms our results of [Theorem 8](#thm4.1){ref-type="statement"}.

In [Figure 3](#fig3){ref-type="fig"}, take *S*(0) = *E*(0) = *I*(0) = *Q*(0) = *R*(0) = 0.1, Λ = 0.2, *μ* = 0.55, *β* = 2.65, *γ* = 0.2, *α* = 2.5, *δ* = 0.1, *p* = 0.1, *ε*~1~ = 0.1, *ε*~2~ = 0.1, *λ* = 0.18, *φ* = 0.15, and Δ*t* = 0.01.

In [Figure 3(a)](#fig3){ref-type="fig"}, take *σ*~*i*~ = 0  (*i* = 1,2, 3,4, 5); then $$\begin{matrix}
{R_{1} = \frac{\mu\left( {1 - \delta p} \right)\beta\alpha}{\left( {\delta p + \mu} \right)\left( {\alpha + \mu} \right)\left( {\lambda + \varepsilon_{1} + \gamma + \mu} \right)} = 2.0505 > 1,} \\
\end{matrix}$$which means the disease will persist. As expected, [Figure 3(a)](#fig3){ref-type="fig"} shows the disease persists in real life.

Synchronously, in [Figure 3(b)](#fig3){ref-type="fig"}, take *σ*~1~ = 0.15, *σ*~2~ = 1, *σ*~3~ = 1, *σ*~4~ = 0.5, *σ*~5~ = 0.25. Obviously, [Figure 3(b)](#fig3){ref-type="fig"} shows the exposed, infected, and quarantined individuals go to extinction and we can get that the permanent disease of system ([3](#EEq2){ref-type="disp-formula"}) can die out under stochastic effects. This implies that the stochastic disturbance is conducive to epidemic diseases control.

This work was supported by the National Natural Science Foundation of China (11371230), the SDUST Research Fund (2014TDJH102), and Shandong Provincial Natural Science Foundation, China (ZR2015AQ001).

Conflicts of Interest
=====================

The authors declare that there are no conflicts of interest regarding the publication of this paper.

![Time sequence diagram of system ([5](#EEq3){ref-type="disp-formula"}) for extinction of the disease.](CMMM2018-7873902.001){#fig1}

![(a) represents the solutions of system ([5](#EEq3){ref-type="disp-formula"}); (b)--(f) stand for the density functions of *S*(*t*), *E*(*t*), *I*(*t*), *Q*(*t*), and *R*(*t*), respectively.](CMMM2018-7873902.002){#fig2}

![Time sequence diagram of system ([5](#EEq3){ref-type="disp-formula"}) for persistence and extinction of the disease.](CMMM2018-7873902.003){#fig3}
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